DataMeds AI Reports Pharmacy Unit Corexa Health July Sales Of $600K+ With Annual Run Rate $7M+; Corexa Completes Registration With TrumpRx To Offer Patients Access To Oral GLP-1 Agonist Drugs
DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform
DataMeds AI's pharmacy business made over $600,000 in one month, which could grow to $7 million per year if it keeps going at that speed. The company also registered to help patients get a popular weight-loss medicine, which shows the business is growing into new areas.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.